254 related articles for article (PubMed ID: 34511497)
1. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
3. Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.
Hilal S; Akoudad S; van Duijn CM; Niessen WJ; Verbeek MM; Vanderstichele H; Stoops E; Ikram MA; Vernooij MW
J Alzheimers Dis; 2017; 60(3):977-987. PubMed ID: 28984600
[TBL] [Abstract][Full Text] [Related]
4. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
[TBL] [Abstract][Full Text] [Related]
5. Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.
Al-Janabi OM; Brown CA; Bahrani AA; Abner EL; Barber JM; Gold BT; Goldstein LB; Murphy RR; Nelson PT; Johnson NF; Shaw LM; Smith CD; Trojanowski JQ; Wilcock DM; Jicha GA
J Alzheimers Dis; 2018; 66(3):1095-1104. PubMed ID: 30400099
[TBL] [Abstract][Full Text] [Related]
6. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
Tubi MA; Feingold FW; Kothapalli D; Hare ET; King KS; Thompson PM; Braskie MN;
Neuroimage; 2020 Feb; 206():116327. PubMed ID: 31682983
[TBL] [Abstract][Full Text] [Related]
10. Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly.
Lampe L; Kharabian-Masouleh S; Kynast J; Arelin K; Steele CJ; Löffler M; Witte AV; Schroeter ML; Villringer A; Bazin PL
J Cereb Blood Flow Metab; 2019 Jan; 39(1):36-43. PubMed ID: 29106319
[TBL] [Abstract][Full Text] [Related]
11. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.
Scott JA; Braskie MN; Tosun D; Maillard P; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
Neurobiol Aging; 2016 Dec; 48():48-52. PubMed ID: 27639120
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
[TBL] [Abstract][Full Text] [Related]
15. The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition.
Dadar M; Camicioli R; Duchesne S; Collins DL;
Alzheimers Dement (Amst); 2020; 12(1):e12091. PubMed ID: 33083512
[TBL] [Abstract][Full Text] [Related]
16. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
[TBL] [Abstract][Full Text] [Related]
17. C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers.
Hilal S; Ikram MA; Verbeek MM; Franco OH; Stoops E; Vanderstichele H; Niessen WJ; Vernooij MW
Stroke; 2018 Nov; 49(11):2692-2698. PubMed ID: 30355213
[TBL] [Abstract][Full Text] [Related]
18. The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.
Svärd D; Nilsson M; Lampinen B; Lätt J; Sundgren PC; Stomrud E; Minthon L; Hansson O; van Westen D
PLoS One; 2017; 12(9):e0185239. PubMed ID: 28934374
[TBL] [Abstract][Full Text] [Related]
19. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
[TBL] [Abstract][Full Text] [Related]
20. Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.
Vipin A; Ng KK; Ji F; Shim HY; Lim JKW; Pasternak O; Zhou JH;
Hum Brain Mapp; 2019 May; 40(7):2065-2075. PubMed ID: 30604903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
